Clinical Trials Browser

linaclotide × Gastrointestinal × 90 days × Clear all

NCT05107219 2026-04-07

GCC Agonist Signal in the Small Intestine

Phase 1 Completed

Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux, Gastrointestinal Neoplasms

NCT03796884 2026-04-02

Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms